Medicare Part D support cut amid rising retiree costs

As older Americans continue to grapple with escalating housing expenses, a higher overall cost of living and growing health care costs, new Medicare Part D figures for 2027 could further influence household budgets. Adding to that financial picture, the Trump administration announced it will end a temporary Medicare Part D premium stabilization program after the 2026 contract year, returning standalone prescription drug plans to traditional market conditions beginning in 2027. The Centers for Medicare & Medicaid Services (CMS) announced the change alongside the release of preliminary technical Medicare Part D bid information for the 2027 contract year. The voluntary Part D Premium Stabilization Demonstration was introduced in 2025 following benefit changes required under the Inflation Reduction Act — designed to reduce premium volatility for standalone prescription drug plans as insurers adapted to the redesigned Part D benefit. According to CMS, insurers now have sufficient experience under the updated benefit structure to accurately develop bids without additional support. As a result, the agency said the initiative will conclude at the end of 2026, with the standalone Part D...